Post Traumatic Stress Disorder (PTSD) in Australian servicemen is a significant issue. The Australian Defence Force (ADF) has reported that about 8.3% of personnel would have experienced PTSD in the last 12 months. In males the occurrence is about twice what it is in the general community.
The ABC news reports that a new Australian-first trail is being undertaken to assess the use of Cannabidiol (CBD) in treating ADF personnel suffering from PTSD.
This article titled What is Cannabidiol (CBD)? will explain much more about what CBD is.
The trial, launched today, is designed to target defensive personnel who have not responded to traditional treatments. The trial by Cannabis Access Clinics in conjunction with BOD Australia will run over the next 12 months.
The coordinators are looking for 300 persons nationally, to take part in the trial. The participants need to have tried every traditional treatment to be eligible.
“We have to be able to show the Therapeutic Goods Administration that these people have tried everything conventional medicine has to offer,” said Dr Sharron Davis, the lead researcher for the trial.
Participants will be given a baseline dose of CBD oil. Jo Patterson, a BOD Australia spokesperson, says they may start with a dose of 5 milliliters, for up to 5 weeks.
The availability of any product to the general public would, of course, depend on the outcome of the trial. Jo Patterson commented that it could still be at least 5 years before anything would be available.
Dr Davis also said, “I would like to see CBD-only oil reclassified — it has no psychoactive effects whatsoever”.
Image Credits: Soldiers by U.S. Marine Corps photo by Lance Cpl. Robert Sweet [Public domain], via Wikimedia Commons